Notify me when PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 12 | $48,396,092 | +$6,333,100 | -$17,384,783 | -$11,051,683 | AEM, CDNA, DMAC, QQQ, NVGS | 13F-HR | 12 Feb 2026, 16:26 |
| Q3 2025 | 12 | $56,074,701 | +$11,878,581 | -$28,135,855 | -$16,257,274 | AEM, NVGS, CDNA, DMAC, AMG | 13F-HR | 12 Nov 2025, 12:41 |
| Q2 2025 | 15 | $62,955,690 | +$22,445,640 | -$6,901,180 | +$15,544,460 | AEM, NVGS, SPY, EPSN, STKL | 13F-HR | 13 Aug 2025, 15:23 |
| Q1 2025 | 13 | $42,664,360 | +$4,553,219 | -$6,802,235 | -$2,249,016 | AEM, NVGS, EPSN, BELFB, NPKI | 13F-HR | 13 May 2025, 15:33 |
| Q4 2024 | 12 | $43,242,302 | +$5,772,848 | -$18,017,895 | -$12,245,047 | AEM, NVGS, BELFB, EPSN, FNV | 13F-HR | 12 Feb 2025, 14:01 |
| Q3 2024 | 16 | $55,680,978 | +$16,100,710 | -$4,640,375 | +$11,460,335 | NVGS, AEM, SPY, BELFB, EPSN | 13F-HR | 14 Nov 2024, 14:59 |
| Q2 2024 | 11 | $40,886,635 | +$4,133,150 | -$20,726,289 | -$16,593,139 | NVGS, AEM, NEM, EPSN, BELFB | 13F-HR | 13 Aug 2024, 14:54 |
| Q1 2024 | 16 | $56,088,610 | +$19,333,910 | -$9,165,800 | +$10,168,110 | NVGS, AEM, EPSN, PBF, VLO | 13F-HR | 14 May 2024, 14:36 |
| Q4 2023 | 15 | $43,599,950 | +$14,859,050 | -$3,486,823 | +$11,372,227 | NVGS, AEM, EPSN, UBS, ECVT | 13F-HR | 14 Feb 2024, 11:31 |
| Q3 2023 | 10 | $30,517,474 | +$3,631,374 | -$22,058,915 | -$18,427,541 | NVGS, AEM, EPSN, IRIX, AR | 13F-HR | 14 Nov 2023, 13:21 |
| Q2 2023 | 13 | $48,870,665 | +$9,773,900 | -$10,776,136 | -$1,002,236 | NVGS, AEM, URI, CF, EPSN | 13F-HR | 14 Aug 2023, 11:53 |
| Q1 2023 | 11 | $48,057,021 | +$11,555,950 | -$18,211,600 | -$6,655,650 | NVGS, AEM, URI, EPSN, ALSN | 13F-HR | 15 May 2023, 12:16 |
| Q4 2022 | 17 | $53,680,445 | +$16,112,146 | -$17,328,026 | -$1,215,880 | NVGS, EPSN, APA, URI, AEM | 13F-HR | 13 Feb 2023, 13:48 |
| Q3 2022 | 12 | $49,537,000 | +$15,477,293 | -$16,400,051 | -$922,758 | APA, NVGS, EPSN, SPY, AR | 13F-HR | 14 Nov 2022, 14:03 |
| Q2 2022 | 11 | $51,206,000 | +$6,427,243 | -$1,934,162 | +$4,493,081 | NVGS, AR, AEM, EPSN, APA | 13F-HR | 16 Aug 2022, 13:34 |
| Q1 2022 | 7 | $53,676,000 | +$1,335,695 | -$21,995,000 | -$20,659,305 | NVGS, AEM, APA, AR, EPSN | 13F-HR | 16 May 2022, 12:33 |
| Q4 2021 | 10 | $62,519,000 | +$14,432,000 | -$40,315,000 | -$25,883,000 | SPY, NVGS, AEM, EPSN, APA | 13F-HR | 14 Feb 2022, 16:08 |
| Q3 2021 | 17 | $88,448,000 | +$38,789,122 | -$21,455,609 | +$17,333,513 | SPY, NVGS, EPSN, VRS, AR | 13F-HR | 15 Nov 2021, 16:01 |
| Q2 2021 | 16 | $75,163,000 | +$19,175,600 | -$20,468,234 | -$1,292,634 | NVGS, RETA, MLKN, IRIX, EPSN | 13F-HR | 16 Aug 2021, 13:06 |
| Q1 2021 | 11 | $65,607,000 | +$9,141,037 | -$9,818,388 | -$677,351 | NEM, NVGS, RETA, IRIX, EPSN | 13F-HR | 14 May 2021, 12:42 |
| Q4 2020 | 10 | $65,028,000 | +$7,521,486 | -$27,141,243 | -$19,619,757 | RETA, NEM, NVGS, EPSN, BK | 13F-HR | 12 Feb 2021, 09:41 |
| Q3 2020 | 8 | $74,494,000 | +$17,710,380 | -$25,976,075 | -$8,265,695 | SPY, NEM, RETA, NVGS, GOLD | 13F-HR | 13 Nov 2020, 16:07 |
| Q2 2020 | 10 | $91,041,000 | +$8,362,346 | -$26,834,232 | -$18,471,886 | RETA, NEM, GOLD, NVGS, ABBV | 13F-HR | 14 Aug 2020, 12:05 |
| Q1 2020 | 13 | $93,109,000 | +$24,014,664 | -$79,788,583 | -$55,773,919 | RETA, NEM, QQQ, SPY, GOLD | 13F-HR | 15 May 2020, 10:15 |
| Q4 2019 | 19 | $177,972,000 | +$12,871,618 | -$10,090,750 | +$2,780,868 | RETA, HUM, OXY, NEM, NVGS | 13F-HR | 13 Feb 2020, 13:28 |
| Q3 2019 | 21 | $129,601,000 | +$24,832,924 | -$19,619,122 | +$5,213,802 | RETA, NEM, HUM, ABBV, OXY | 13F-HR | 13 Nov 2019, 15:51 |
| Q2 2019 | 25 | $129,831,000 | +$42,844,666 | -$24,857,633 | +$17,987,033 | RETA, HUM, OXY, NEM, NVGS | 13F-HR | 14 Aug 2019, 12:10 |
| Q1 2019 | 30 | $106,029,000 | +$43,561,250 | -$27,408,938 | +$16,152,312 | RETA, NVGS, NEM, PARR, IRIX | 13F-HR | 14 May 2019, 12:43 |
| Q4 2018 | 21 | $75,301,000 | +$17,998,095 | -$9,910,250 | +$8,087,845 | RETA, NVGS, JPM, AGN, IRIX | 13F-HR | 13 Feb 2019, 13:40 |
| Q3 2018 | 19 | $87,704,000 | +$9,202,360 | -$15,242,163 | -$6,039,803 | RETA, NVGS, IRIX, AGN, PARR | 13F-HR | 14 Nov 2018, 13:01 |
| Q2 2018 | 23 | $75,315,000 | +$17,717,750 | -$17,551,618 | +$166,132 | NVGS, RETA, IRIX, AGN, QADA | 13F-HR | 14 Aug 2018, 14:26 |
| Q1 2018 | 16 | $68,620,000 | +$12,495,596 | -$59,668,833 | -$47,173,237 | NVGS, IRIX, AGN, OXY, RETA | 13F-HR | 15 May 2018, 16:08 |
| Q4 2017 | 20 | $120,212,000 | +$31,946,932 | -$30,746,062 | +$1,200,870 | SPY, C, NVGS, DAL, OXY | 13F-HR | 13 Feb 2018, 15:14 |
| Q3 2017 | 23 | $117,112,000 | +$33,894,683 | -$15,324,045 | +$18,570,638 | NVGS, IRIX, SPY, C, PARR | 13F-HR | 13 Nov 2017, 13:13 |
| Q2 2017 | 15 | $85,631,000 | +$29,683,563 | -$27,243,429 | +$2,440,134 | SPY, IRIX, PARR, NVGS, C | 13F-HR | 14 Aug 2017, 11:43 |
| Q1 2017 | 20 | $93,022,000 | +$20,419,685 | -$5,384,804 | +$15,034,881 | NVGS, IRIX, PARR, MYL, ESXB | 13F-HR | 15 May 2017, 13:13 |
| Q4 2016 | 16 | $75,208,000 | +$9,293,235 | -$23,032,808 | -$13,739,573 | IRIX, NVGS, PARR, ESXB, RETA | 13F-HR | 13 Feb 2017, 15:38 |
| Q3 2016 | 15 | $86,523,000 | +$8,354,986 | -$21,258,865 | -$12,903,879 | IRIX, PARR, BSFT, NVGS, ESXB | 13F-HR | 14 Nov 2016, 16:04 |
| Q2 2016 | 18 | $102,161,000 | +$25,773,820 | -$41,881,473 | -$16,107,653 | IRIX, YHOO, PARR, NVGS, BSFT | 13F-HR | 15 Aug 2016, 11:40 |
| Q1 2016 | 17 | $119,270,000 | +$24,371,145 | -$26,194,300 | -$1,823,155 | CSCD, NVGS, PARR, IRIX, YHOO | 13F-HR | 13 May 2016, 11:48 |
| Q4 2015 | 18 | $117,020,000 | +$16,551,410 | -$3,931,671 | +$12,619,739 | PARR, CSCD, DAL, IRIX, NVGS | 13F-HR | 12 Feb 2016, 18:01 |
| Q3 2015 | 19 | $93,594,000 | +$14,533,810 | -$26,767,657 | -$12,233,847 | PARR, CSCD, DAL, NVGS, IRIX | 13F-HR | 13 Nov 2015, 17:12 |
| Q2 2015 | 23 | $115,626,000 | +$29,272,628 | -$26,101,015 | +$3,171,613 | MET, CSCD, NVGS, ISCA, DAL | 13F-HR | 13 Aug 2015, 16:13 |
| Q1 2015 | 16 | $114,475,000 | +$35,062,573 | -$81,549,078 | -$46,486,505 | NVGS, CSCD, PARR, DAL, C | 13F-HR | 14 May 2015, 18:08 |
| Q4 2014 | 19 | $157,783,000 | +$23,994,856 | -$16,229,200 | +$7,765,656 | AAL, C, BAC, CSCD, HON | 13F-HR | 13 Feb 2015, 07:49 |
| Q3 2014 | 17 | $134,718,000 | +$30,440,635 | -$13,150,714 | +$17,289,921 | C, AAL, BAC, HON, GLD | 13F-HR | 14 Nov 2014, 13:15 |
| Q2 2014 | 20 | $125,321,000 | +$47,067,224 | -$22,079,073 | +$24,988,151 | AAL, GLD, HON, MET, BAC | 13F-HR | 13 Aug 2014, 15:45 |
| Q1 2014 | 16 | $100,294,000 | +$10,006,733 | -$76,772,714 | -$66,765,981 | AAL, WPX, MET, UAL, IRIX | 13F-HR | 12 May 2014, 18:32 |
| Q4 2013 | 20 | $148,751,000 | $0 | $0 | $0 | SPNC, UAL, MET, AAL, LM | 13F-HR | 14 Feb 2014, 14:12 |